Powell’s speech, Nvidia’s chips, Meta deal - what’s moving markets
In a recent transaction filed with the Securities and Exchange Commission, Carl Schweihs, Executive Vice President and Chief Financial Officer of TrueBlue, Inc. (NYSE:TBI), purchased 2,500 shares of the company’s common stock. The shares were acquired at a price of $5.25 each, totaling $13,125. The purchase comes as TrueBlue trades near its 52-week low of $5.19, with the stock down over 54% in the past year. According to InvestingPro data, the company currently has a market capitalization of $160 million and trades at a price-to-book ratio of 0.51.
Following this purchase, Schweihs holds a total of 169,051 shares in the company. This figure includes approximately 5,861 shares acquired through the TrueBlue Employee Stock Purchase Plan. The transaction was executed in multiple trades, all at the same price of $5.25 per share. InvestingPro analysis reveals 17 additional investment tips for TrueBlue, including insights on management’s share buyback activity and valuation metrics. Get access to the complete TrueBlue Pro Research Report, part of InvestingPro’s coverage of 1,400+ US stocks.
In other recent news, TrueBlue Inc . has announced the acquisition of Healthcare Staffing Professionals, Inc. (HSP), a company focused on healthcare staffing for government entities. This strategic move aims to strengthen TrueBlue’s presence in high-growth markets and capitalize on the increasing demand within the healthcare sector. The acquisition was conducted off-market, allowing HSP to retain its brand identity while benefiting from TrueBlue’s national reach and advanced recruitment technology. Taryn Owen, President and CEO of TrueBlue, emphasized the combined capabilities of both companies to meet the growing needs of the healthcare market. Maxie Juzang, CEO and President of HSP, expressed excitement about joining TrueBlue, highlighting the potential for accelerated growth and revenue synergies. Carl Schweihs, TrueBlue’s Chief Financial Officer, described the acquisition as accretive and synergistic, noting that it was financed using the company’s strong balance sheet with modest debt at favorable terms. Further financial details are expected to be disclosed in TrueBlue’s upcoming fourth-quarter earnings call. The transaction terms have not been publicly disclosed.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.